SCHEMBL7073829

SCHEMBL7073829

Clc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29054 1.00
Hydrogen Sulfide SCHEMBL29248841 0.97
SCHEMBL6830319 0.97
Ammonia Solution, Strong SCHEMBL28811677 0.97
SCHEMBL3276946 0.97
SCHEMBL2975655 0.97
SCHEMBL497681 0.97
SCHEMBL8666743 0.97
Thiophene SCHEMBL8139431 0.89 FBP1 (0.35)
SCHEMBL911609 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740658-B1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS ABBOTT GMBH & CO KG (DE) 2003-07-02 EP disclosed
EP-0731802-B1 N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES AS NEUROLEPTICS ETC. BASF AG (DE) 2000-07-12 EP disclosed
US-5703091-A N-substituted azabicycloalkane derivatives, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 1997-12-30 US disclosed
EP-0731802-A1 N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES AS NEUROLEPTIKA ASF BASF AKTIENGESELLSCHAFT (DE) 1996-09-18 EP disclosed
WO-1995015327-A1 N-SUBSTITUTED AZABICYCLOALKANE DERIVATIVES AS NEUROLEPTIKA ASF BASF AKTIENGESELLSCHAFT (DE) 1995-06-08 WO disclosed